Axial Spondylarthritis (axSpA) Clinical Trials

16 clinical trials for Axial Spondylarthritis (axSpA) across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA. — RECRUITING · PHASE2
• Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor — RECRUITING
• Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy — RECRUITING
• Initial Standardized Global Review in Axial Spondyloarthritis — RECRUITING · NA
• A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS — RECRUITING
• A MULTICENTER, LONG-TERM EXTENSION STUDY OF 104 WEEKS, INCLUDING A DOUBLE-BLIND, PLACEBO-CONTROLLED 40-WEEK RANDOMIZED WITHDRAWAL-RETREATMENT PERIOD, TO EVALUATE THE MAINTENANCE OF TREATMENT EFFECT OF IXEKIZUMAB (LY2439821) IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS — RECRUITING
• A 52-WEEK MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IXEKIZUMAB (LY2439821) IN BDMARD NAIVE PATIENTS WITH NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 16-WEEK STUDY FOLLOWED BY LONG-TERM EVALUATION OF EFFICACY AND SAFETY OF IXEKIZUMAB (LY2439821) IN TNFI-EXPERIENCED PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO-CONTROLLED 16-WEEK STUDY FOLLOWED BY LONG-TERM EVALUATION OF EFFICACY AND SAFETY OF IXEKIZUMAB (LY2439821) IN BDMARD-NAIVE PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS, — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN LABEL EXTENSION TO EVALUATE THE SAFETY AND EFFICACY OF BRODALUMAB IN SUBJECTS WITH AXIAL SPONDYLOARTHRITIS — RECRUITING
• The REFLECT Study- Flares in axSpA — ACTIVE_NOT_RECRUITING
• A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting — ACTIVE_NOT_RECRUITING
• A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib — COMPLETED
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis — NOT_YET_RECRUITING · PHASE4
• Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis — COMPLETED
• Ultrasonographic Assessment of Thoracolumbar Fascia in AxSpA and Controls With Trigger Point Evaluation — COMPLETED

Refine this search